Triple-helix structure binds cell-surface receptors (e.g. Dectin-1) and modulates NF-κB/MAPK signalling, reinforcing the skin barrier and remodelling senescent micro-environments. For barrier fragility from inflammatory premature aging, photoaging or microbial imbalance. INCI: Schizophyllan, 1,2-Hexanediol, Ethylhexylglycerin, Water. Recommended use level: 0.5%-10.0%.